Citations

Clear

8 citation(s) found for "Sucha, D".

Deep Learning-Based Deblurring for Computed Tomography and a Phantom Evaluation for Coronary Artery Calcium Detectability
Werf, Niels R. van der , Huber, Nathan R., Leiner, Tim , Wuelker, Christian, Schnellbaecher, Nikolas D., Greuter, Marcel J.W. , Graß, Michael , Leiner, Tim , Huber, Nathan R. , Suchá, Dominika , Wülker, Christian , Schnellbächer, Nikolas D.

Mayo Clinic

Journal of Computer Assisted Tomography | July 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/rct.0000000000001897 | PMID 42417480 Get It

Introduction: This study aimed to develop and evaluate a deep learning (DL) deblurring algorithm for computed tomography (CT). Phantom testing assessed whether DL deblurring could improve CT image quality and coronary artery calcium (CAC) detectability. Materials and Methods: The algorithm consisted of 2 sequential convolutional neural networks (CNNs): one for denoising and one for deblurring. After deblurring, the estimated noise from the first model was reintroduced to preserve image texture. The CNN denoising model was trained to map high-noise images to routine low-noise ones. The CNN deblurring model was trained using natural images—blurred inputs paired with sharp targets. To assess performance, an anthropomorphic phantom with 100 small calcifications was scanned on a CT system using a CAC scoring protocol. Data were acquired at clinical and high doses, then reconstructed with and without DL deblurring, using 25% of the maximum denoising strength. Detectability was defined as the ability to calculate an Agatston score (≥3 adjacent voxels >130 HU). Results: At high dose, CAC detectability increased from 39% (standard reconstruction) to 48% with deblurring. Similar detectability (39%) was achieved at the routine dose with deblurring, representing a 6% improvement compared with the original routine dose data. Discussion: Quantitative results from phantom testing demonstrate that DL deblurring can improve image quality, based on a clinically relevant, task-based CAC detection metric at clinical dose levels.
Radiology: Cardiothoracic Imaging Highlights 2025
Sanchez, Daniel Alfonso Pinos , Farias, Lucas de Pádua Gomes de , Onnis, Carlotta , Escalon, Joanna G. , Hanneman, Kate , Litt, Harold , Gulsin, Gaurav S. , Pinos, Daniel , Gomes de Farias, Lucas de Pádua , Suchá, Dominika , Escalon, Joanna G , Hanneman, Kate , Abbara, Suhny , Litt, Harold I , Gulsin, Gaurav S , Suchá, Dominika , Mastrodicasa, Domenico

Mayo Clinic

Radiology: Cardiothoracic Imaging | June 11, 2026 | Volume: 8 | Issue: 3 | Pages: No page available

10.1148/ryct.260065 | PMID 42274320 Get It

Articles published in Radiology: Cardiothoracic Imaging in 2025 highlight advances in cardiothoracic imaging through technical innovation, quantitative biomarkers, and artificial intelligence applications that support improved diagnosis, risk stratification, and patient-centered management across cardiac, vascular, and thoracic disease.
Multicenter cardiovascular magnetic resonance reference ranges and severity grading for ventricular and atrial measurements: insights from the healthy hearts consortium
Szabo, L E, McCracken, Celeste , Condurache, D G, Aquaro, G D, Andre, F, Sucha, D, Harvey, N C, Leiner, Tim, Chin, C W L, Friedrich, M G, Barison, A, Dörr, M, Raisi-Estabragh, Z, Petersen, S E, Condurache, Dorina-Gabriela , Bulow, R, Aquaro, Giovanni Donato , Andre, F, Suchá, Dominika , Leiner, Tim , Friedrich, Matthias G. , Dörr, Marcus , Raisi‐Estabragh, Zahra , Petersen, S E

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.219 Get It

Abstract Introduction Cardiovascular magnetic resonance (CMR) imaging enables precise, non-invasive assessment of cardiac structure and function, yet the clinical utility of CMR metrics is limited by the lack of comprehensive, population-specific reference values. By directly reanalyzing data from a large, multi-ethnic cohort rather than relying solely on pooled literature, could enable the establishment of standardized reference ranges and severity grading thresholds. Aim To provide comprehensive, age-, sex-, and ethnicity-stratified CMR reference ranges and severity grading thresholds for key ventricular and atrial parameters. Methods We analyzed over 9,000 CMR scans from the Healthy Hearts Consortium (HHC), comprising six international cohorts. All individuals were free from overt cardiovascular disease and major comorbidities, ensuring a verified healthy sample. Two automated segmentation software solutions—cvi42 (Circle Cardiovascular Imaging) and suiteHEART (Neosoft)—were used to quantify left and right ventricular volumes, myocardial mass, and atrial volumes in standard cine stacks. All endorsed segmentation modes were applied. Quality control protocol combined expert visual review and statistical outlier analysis. We derived 95% prediction intervals (PI) to define the normal range, with additional severity thresholds for mild (95–99.73% PI), moderate (99.73–99.99% PI), and severe (>99.99% PI) deviation from the reference range. Results The final dataset comprised of 9,059 verified healthy adults aged 18–83 years (mean 61 ± 13 years), with a near-equal sex distribution (51% women). Demographics included White (81.6%), South Asian (5.6%), Mixed/Other (5.3%), Black (3.8%), and Chinese (3.7%) participants. Results demonstrated that sex, age, and ethnicity strongly influenced cardiac indices. Men had higher indexed LV and RV volumes and greater myocardial mass than women. Black participants presented the highest indexed LV myocardial mass across age groups, whereas Chinese participants had comparatively lower myocardial mass values (Figure 1). In contrast, atrial volumes remained relatively stable across age categories. Comparative analysis showed minor differences between the two software tools, particularly for atrial parameters; however, derived ejection fractions remained consistent. We established age-, sex-, and ethnicity-stratified reference ranges for key CMR parameters. To facilitate clinical interpretation, we defined severity thresholds corresponding to mild, moderate, and severe abnormalities. Conclusion This large-scale, international effort addresses prior limitations in CMR interpretation by offering robust, contemporary reference ranges and severity grading applicable to diverse populations and imaging protocols. Our severity grading thresholds support consistency in clinical reporting and decision-making, enabling clearer identification of early subclinical changes and more accurate monitoring of disease progression.Subset of CMR value ranges in females
Radiology: Cardiothoracic Imaging Highlights 2024
Catania, Roberta , Mukherjee, Aprateem , Chamberlin, Jordan , Calle, Francisco , Philomina, Preethi , Mastrodicasa, Domenico , Allen, Bradley D. , Hanneman, Kate , Chamberlin, Jordan H , Suchá, Dominika , Abbara, Suhny , Hanneman, Kate , Allen, Bradley A , Catania, Roberta , Suchá, Dominika

Mayo Clinic

Radiology: Cardiothoracic Imaging | June 5, 2025 | Volume: 7 | Issue: 3 | Pages: No page available

10.1148/ryct.250064 | PMID 40471074 Get It

The field of cardiothoracic imaging is expanding rapidly with new techniques that enable greater diagnostic accuracy and more personalized patient management, ultimately improving outcomes and enhancing clinical decision-making.
Fetal Cardiovascular Magnetic Resonance: History, Current Status, and Future Directions
Suchá, Dominika , Bohte, Anneloes E. , Leiner, Tim , Schrauben, Eric , Grotenhuis, Heynric B. , Leiner, Tim , Schrauben, Eric M , Grotenhuis, Heynric B , Suchá, Dominika , Ooij, Pim van

Mayo Clinic

Journal of Magnetic Resonance Imaging | November 23, 2024 | Volume: 61 | Issue: 6 | Pages: 2357-2375

10.1002/jmri.29664 | PMID 39578988 Get It

Fetal cardiovascular magnetic resonance imaging (MRI) has emerged as a complementary modality for prenatal imaging in suspected congenital heart disease. Ongoing technical improvements extend the potential clinical value of fetal cardiovascular MRI. Ascertaining equivocal prenatal diagnostics obtained with ultrasonography allows for appropriate parental counseling and planning of postnatal surgery. This work summarizes current acquisition techniques and clinical applications of fetal cardiovascular MRI in the prenatal diagnosis and follow‐up of fetuses with congenital heart disease.Level of Evidence3Technical EfficacyStage 3
Muc1 Modulates the Beta‐Catenin Protective Pathway During Ischemia‐Reperfusion Injury
Kinlough, Carol L., Poland, Paul A., Gendler, Sandra , Madsen, Cathy S., Singh, Sucha , Bastacky, Sheldon , Hughey, Rebecca P. , Al‐bataineh, Mohammad M. , Pastor‐Soler, Núria M. , Sutton, Timothy A. , Mang, Henry Elmer , Monga, Satdarshan P.

Mayo Clinic

The FASEB Journal | November 26, 2023 | Volume: 30 | Issue: S1 | Pages: No page available

10.1096/fasebj.30.1_supplement.1217.5 Get It

The HIF‐1 and β‐catenin protective pathways represent the two most significant cellular responses that are activated in response to acute kidney injury. We previously reported that murine Mucin 1 (Muc1) protects kidney function and morphology in a mouse model of ischemia‐reperfusion injury (IRI) by stabilizing HIF‐1α, enhancing HIF‐1 downstream signaling and thereby preventing metabolic stress (Pastor‐Soler et al. 2015 Am. J. Physiol. Renal Physiol. 308, F1452‐F1462). We asked if Muc1 regulates the β‐catenin protective pathway during IRI as published data indicate that (i) β‐catenin is found in co‐immunoprecipitates with human MUC1 in extracts of both cultured cells and tissues, (ii) β‐catenin nuclear targeting is MUC1‐dependent in cultured human cells, and (iii) MUC1 prevents β‐catenin phosphorylation by glycogen synthase kinase 3β (GSK3b) and thereby β‐catenin degradation. Using our same mouse model of IRI, and by using immunohistochemistry and immunoblotting of kidney tissue, we found that levels of active GSK3β were significantly lower in kidneys of control mice compared to Muc1 KO mice. Consequently, β‐catenin was significantly increased at 24 and 72 h recovery and appeared in the nuclear fraction at 72 h in control mouse kidneys. Both β‐catenin induction and nuclear targeting were absent in Muc1 KO mice. In accord with these data, we also found downstream induction of β‐catenin pro‐survival factors (activated Akt, survivin, transcription factor TCF4 and its downstream target cyclin D1) and repression of pro‐apoptotic factors (p53, active Bax and cleaved caspase 3) in control mouse kidneys that were absent or aberrant in kidneys of Muc1 KO mice. Altogether, the data clearly indicate that Muc1 protection during AKI proceeds by enhancing both the HIF‐1 and β‐catenin protective pathways. Support or Funding Information This work was supported by National Institutes of Health (NIH) Grants DK‐099345 (to T. A. Sutton), DK‐084184 (to N. M. Pastor‐Soler), CA‐64389 (to S. J. Gendler), DK‐62277, DK‐100287, and DK‐095498 (to S. P. Monga), DK‐097889 (to M. M. Al‐bataineh), DK107632, DK‐079307 (Pilot Project) and Samuel and Emma Winters Foundation grant (to R. P. Hughey), and P30‐DK079307 (to the Microscopy Core N. M. Pastor‐Soler and S. Bastacky).
Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury
Al‐bataineh, Mohammad M. , Kinlough, Carol L., Poland, Paul A., Pastor‐Soler, Núria M. , Sutton, Timothy A. , Bastacky, Sheldon , Gendler, Sandra , Madsen, Cathy S., Singh, Sucha , Monga, Satdarshan P. , Hughey, Rebecca P. , Gendler, Sandra J, Mang, Henry Elmer , Monga, Satdarshan

Mayo Clinic

American Journal of Physiology-Renal Physiology | January 7, 2016 | Volume: 310 | Issue: 6 | Pages: F569-F579

10.1152/ajprenal.00520.2015 | PMID 26739894 Get It

The hypoxia-inducible factor (HIF)-1 and β-catenin protective pathways represent the two most significant cellular responses that are activated in response to acute kidney injury. We previously reported that murine mucin (Muc)1 protects kidney function and morphology in a mouse model of ischemia-reperfusion injury (IRI) by stabilizing HIF-1α, enhancing HIF-1 downstream signaling, and thereby preventing metabolic stress (Pastor-Soler et al. Muc1 is protective during kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 308: F1452–F1462, 2015). We asked if Muc1 regulates the β-catenin protective pathway during IRI as 1) β-catenin nuclear targeting is MUC1 dependent in cultured human cells, 2) β-catenin is found in coimmunoprecipitates with human MUC1 in extracts of both cultured cells and tissues, and 3) MUC1 prevents β-catenin phosphorylation by glycogen synthase kinase (GSK)3β and thereby β-catenin degradation. Using the same mouse model of IRI, we found that levels of active GSK3β were significantly lower in kidneys of control mice compared with Muc1 knockout (KO) mice. Consequently, β-catenin was significantly upregulated at 24 and 72 h of recovery and appeared in the nuclear fraction at 72 h in control mouse kidneys. Both β-catenin induction and nuclear targeting were absent in Muc1 KO mice. We also found downstream induction of β-catenin prosurvival factors (activated Akt, survivin, transcription factor T cell factor 4 (TCF4), and its downstream target cyclin D1) and repression of proapoptotic factors (p53, active Bax, and cleaved caspase-3) in control mouse kidneys that were absent or aberrant in kidneys of Muc1 KO mice. Altogether, the data clearly indicate that Muc1 protection during acute kidney injury proceeds by enhancing both the HIF-1 and β-catenin protective pathways.
Muc1 is protective during kidney ischemia-reperfusion injury
Pastor‐Soler, Núria M. , Sutton, Timothy A. , Kinlough, Carol L., Gendler, Sandra , Madsen, Cathy S., Bastacky, Sheldon , Ho, Jacqueline , Al‐bataineh, Mohammad M. , Hallows, Kenneth R. , Singh, Sucha , Monga, Satdarshan P. , Kobayashi, Hanako , Haase, Volker H. , Hughey, Rebecca P. , Gendler, Sandra J, Mang, Henry Elmer , Monga, Satdarshan

Mayo Clinic

American Journal of Physiology-Renal Physiology | April 30, 2015 | Volume: 308 | Issue: 12 | Pages: F1452-F1462

10.1152/ajprenal.00066.2015 | PMID 25925251 Get It

Ischemia-reperfusion injury (IRI) due to hypotension is a common cause of human acute kidney injury (AKI). Hypoxia-inducible transcription factors (HIFs) orchestrate a protective response in renal endothelial and epithelial cells in AKI models. As human mucin 1 (MUC1) is induced by hypoxia and enhances HIF-1 activity in cultured epithelial cells, we asked whether mouse mucin 1 (Muc1) regulates HIF-1 activity in kidney tissue during IRI. Whereas Muc1 was localized on the apical surface of the thick ascending limb, distal convoluted tubule, and collecting duct in the kidneys of sham-treated mice, Muc1 appeared in the cytoplasm and nucleus of all tubular epithelia during IRI. Muc1 was induced during IRI, and Muc1 transcripts and protein were also present in recovering proximal tubule cells. Kidney damage was worse and recovery was blocked during IRI in Muc1 knockout mice compared with congenic control mice. Muc1 knockout mice had reduced levels of HIF-1α, reduced or aberrant induction of HIF-1 target genes involved in the shift of glucose metabolism to glycolysis, and prolonged activation of AMP-activated protein kinase, indicating metabolic stress. Muc1 clearly plays a significant role in enhancing the HIF protective pathway during ischemic insult and recovery in kidney epithelia, providing a new target for developing therapies to treat AKI. Moreover, our data support a role specifically for HIF-1 in epithelial protection of the kidney during IRI as Muc1 is present only in tubule epithelial cells.